DNA甲基化驱动的转录表达特征作为肝癌预后预测标志物的价值

doi:10.16288/j.yczz.20-139

[an error occurred while processing this directive]

Hereditas(Beijing) ›› 2020, Vol. 42 ›› Issue (8): 775-787.doi: 10.16288/j.yczz.20-139

• Research Article • Previous Articles Next Articles

Prognostic and predictive value of a DNA methylation-driven transcriptional signature in hepatocellular carcinoma

Hongbo Luo¹, Pengbo Cao²(), Gangqiao Zhou^1,²()

^1. Guizhou University School of Medicine, Guiyang 550025, China
^2. State Key Lab of Proteomics, National Center for Protein Sciences (Beijing), Institute of Radiation Medicine, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100850, China;

Received:2020-05-18 Revised:2020-07-10 Online:2020-08-20 Published:2020-07-10
Contact: Cao Pengbo,Zhou Gangqiao E-mail:birchcpb@163.com;zhougq114@126.com
Supported by:
Supported by the National S&T Major Project Nos(2018ZX10732202);Supported by the National S&T Major Project Nos(2017ZX10203205)

Abstract

Abstract:

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. DNA methylation alterations are frequently observed in malignant tumours and play critical roles in the development of cancers, including HCC. To provide novel clinical prognosis biomarkers for HCC patients, we first performed a comprehensive analysis and identified a collection of prognosis-associated genes with DNA methylation-driven expression dysregulation in HCCs. Then, we optimally established a 10-gene prognostic risk score model using the least absolute shrinkage and selection operator (LASSO) analysis. Cox's proportional hazards regression analysis revealed that the high-risk score is significantly associated with poor prognosis after being adjusted by clinical parameters, indicating its potential prognostic value. The receiver operating characteristic curve (ROC) analysis showed that this 10-gene prognostic risk score model outperformed several other publicly available models in predicting both short- and long-term prognosis. Gene set enrichment analysis revealed that the high-risk score is relevantly associated with pathways involved in cell cycle and DNA damage repair. The above results indicate that we have constructed a 10-DNA-methylation-driven-gene prognostic risk score model, which might serve as a potential prognostic biomarker for HCC patients and guide treatment decisions for patients at high risk of tumour progression.

Key words: hepatocellular carcinoma, transcriptome, epigenome, prognostic model

Hongbo Luo, Pengbo Cao, Gangqiao Zhou. Prognostic and predictive value of a DNA methylation-driven transcriptional signature in hepatocellular carcinoma[J]. Hereditas(Beijing), 2020, 42(8): 775-787.

Figures/Tables 8

Table 1

Fig. 1

Table 2

Fig. 2

Fig. 3

Fig. 4

Fig. 5

References 27

[1]	Villanueva A . Hepatocellular carcinoma. N Engl J Med, 2019,380(15):1450-1462. doi: 10.1056/NEJMra1713263 pmid: 30970190
[2]	Samonakis DN, Kouroumalis EA . Systemic treatment for hepatocellular carcinoma: still unmet expectations. World J Hepatol, 2017,9(2):80-90. doi: 10.4254/wjh.v9.i2.80 pmid: 28144389
[3]	Zhang JW, Xu Q, Li GL . Epigenetics in the genesis and development of cancers. Hereditas(Beijing), 2019,41(7):567-581. doi: 10.16288/j.yczz.19-077 pmid: 31307967
	张競文, 续倩, 李国亮 . 癌症发生发展中的表观遗传学研究. 遗传, 2019,41(7):567-581. doi: 10.16288/j.yczz.19-077 pmid: 31307967
[4]	Sun LY, Li XY, Sun ZW . Progress of epigenetics and its therapeutic application in hepatocellular carcinoma. Hereditas(Beijing), 2015,37(6):517-527. doi: 10.16288/j.yczz.14-443 pmid: 26351047
	孙凌云, 李星逾, 孙志为 . 原发性肝癌的表观遗传学及其治疗. 遗传, 2015,37(06):517-527. doi: 10.16288/j.yczz.14-443 pmid: 26351047
[5]	Tan AC, Jimeno A, Lin SH, Wheelhouse J, Chan F, Solomon A, Rajeshkumar NV, Rubio-Viqueira B, Hidalgo M . Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol, 2009,3(5-6):425-438. doi: 10.1016/j.molonc.2009.03.004 pmid: 19497796
[6]	Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR . STAR: ultrafast universal RNA-seq aligner. Bioinformatics, 2013,29(1):15-21. doi: 10.1093/bioinformatics/bts635
[7]	Kim D, Langmead B, Salzberg SL . HISAT: a fast spliced aligner with low memory requirements. Nat Methods, 2015,12(4):357-360. doi: 10.1038/nmeth.3317 pmid: 25751142
[8]	Love MI, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol, 2014,15(12):550. doi: 10.1186/s13059-014-0550-8 pmid: 25516281
[9]	Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, Beck S . ChAMP: 450k chip analysis methylation pipeline. Bioinformatics, 2014,30(3):428-430. doi: 10.1093/bioinformatics/btt684
[10]	Ritchie ME, Phipson B, Wu D, Hu YF, Law CW, Shi W, Smyth GK . Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res, 2015,43(7):e47. doi: 10.1093/nar/gkv007 pmid: 25605792
[11]	Mah WC, Thurnherr T, Chow PKH, Chung AYF, Ooi LLPJ, Toh HC, Teh BT, Saunthararajah Y, Lee CGL . Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis. PLoS One, 2014,9(8):e104158. doi: 10.1371/journal.pone.0104158 pmid: 25093504
[12]	Friedman J, Hastie T, Tibshirani R . Regularization paths for generalized linear models via coordinate descent. J Stat Softw, 2010,33(1):1-22.
[13]	Blanche P, Dartigues JF, Jacqmin-Gadda H . Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med, 2013,32(30):5381-5397. doi: 10.1002/sim.5958 pmid: 24027076
[14]	Steyerberg EWS, Vergouwe Y . Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J, 2014,35(29):1925-1931. doi: 10.1093/eurheartj/ehu207
[15]	Zheng YJ, Liu YL, Zhao SF, Zheng ZT, Shen CY, An L, Yuan YL . Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma. Cancer Manag Res, 2018, ( 10):6079-6096.
[16]	Yang Y, Lu Q, Shao XJ, Mo BH, Nie XQ, Liu W, Chen XH, Tang Y, Deng YC, Yan J . Development of a three-gene prognostic signature for hepatitis b virus associated heaptocellular carcinoma based on integrated transcriptomic analysis. J Cancer, 2018,9(11):1989-2002. doi: 10.7150/jca.23762 pmid: 29896284
[17]	Long JY, Chen PP, Lin JZ, Bai Y, Yang X, Bian J, Lin Y, Wang DX, Yang XB, Zheng YC, Sang XT, Zhao HT . DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Theranostics, 2019,9(24):7251-7267. doi: 10.7150/thno.31155 pmid: 31695766
[18]	Torgovnick A, Schumacher B . DNA repair mechanisms in cancer development and therapy. Front Genet, 2015,6:157. doi: 10.3389/fgene.2015.00157 pmid: 25954303
[19]	Feitelson MA . Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett, 2006,239(1):10-20. doi: 10.1016/j.canlet.2005.07.009 pmid: 16154256
[20]	Liu LL, Dai YD, Chen JN, Zeng TT, Li Y, Chen LL, Zhu YH, Li JC, Li Y, Ma S, Xie D, Yuan YF, Guan XY . Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. Hepatology, 2014,59(2):531-543. doi: 10.1002/hep.26677
[21]	Zhang ZY, Zhu JF, Huang YS, Li WB, Cheng HQ . MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway. Diagn Pathol, 2018,13(1):85. doi: 10.1186/s13000-018-0763-3 pmid: 30390677
[22]	Cao D, Song XH, Che L, Li XL, Pilo MG, Vidili G, Porcu A, Solinas A, Cigliano A, Pes GM, Ribback S, Dombrowski F, Chen X, Li L, Calvisi DF . Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells. Liver Int, 2017,37(1):80-89. doi: 10.1111/liv.13183 pmid: 27264722
[23]	Liu P, Atkinson SJ, Akbareian SE, Zhou ZG, Munsterberg A, Robinson SD, Bao YP . Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling. Sci Rep, 2017,7(1):12651. doi: 10.1038/s41598-017-12855-w pmid: 28978924
[24]	Wang HX, Wu KJ, Sun Y, Li YD, Wu MY, Qiao Q, Wei YJ, Han ZG, Cai B . STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro. BMB Rep, 2012,45(11):629-634.
[25]	Chen JX, Rajasekaran M, Xia HP, Zhang XQ, Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BKP, Ooi LL, Hong WJ, Hui KM . The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Gut, 2016,65(9):1522-1534. doi: 10.1136/gutjnl-2015-310625 pmid: 26941395
[26]	Desai A, Mitchison TJ . Microtubule polymerization dynamics. Annu Rev Cell Dev Biol, 1997,13:83-117. doi: 10.1146/annurev.cellbio.13.1.83 pmid: 9442869
[27]	Safran M, Dalah I, Alexander J, Rosen N, Stein TI, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, Olender T, Golan Y, Stelzer G, Harel A, Lancet D . GeneCards Version 3: the human gene integrator. Database (Oxford), 2010, 2010: baq020.

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

研究队列	数据集	样本量	数据类型	数据来源
发掘队列	SRP069212	20例配对的癌和癌旁组织	mRNA表达	GEO
	SRP118972	12例癌组织样本和8例癌旁组织	mRNA表达	GEO
	GSE89852	33例配对的癌和癌旁组织	DNA甲基化	GEO
	GSE54503	66例配对的癌和癌旁组织	DNA甲基化	GEO
模型训练队列	TCGA-LIHC	371例癌组织和50例癌旁组织	mRNA表达和DNA甲基化	TCGA
模型训练队列	ICGC-LIRI-JP	203例癌组织	mRNA表达	ICGC
模型验证队列	GSE76427	115例癌组织	基因表达	GEO
模型验证队列	GSE84005	37例癌组织	基因表达	GEO

基因	HR (95% CI)	P值	LASSO系数	基因组变异频率(%)
CDCA8	2.21 (1.54~3.01)	<0.0001	0.1194	0.0
PRC1	1.85 (1.29~2.54)	0.0005	0.08869	0.3
MAPT	1.72 (1.21~2.46)	0.0021	0.2597	1.7
SFN	1.72 (1.21~2.45)	0.0021	0.001652	0.3
STC2	1.73 (1.22~2.43)	0.0021	0.03600	0.8
MYO18B	1.69 (1.19~2.37)	0.0031	0.1932	4.0
PBK	1.67 (1.17~2.35)	0.0036	0.06524	6.0
MAEL	1.55 (1.09~2.17)	0.013	-0.1766	10.0
TTC39A	1.55 (1.09~2.17)	0.013	-0.01347	1.4
LPL	1.55 (1.10~2.18)	0.014	0.003126	7.0

Prognostic and predictive value of a DNA methylation-driven transcriptional signature in hepatocellular carcinoma

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 8

References 27

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Hao Chen, Rui Dong, Yanfeng Wang, Jingbei Xie, Zhaoxu Zhang, Rongquan Zheng. The molecular mechanism of limb regeneration of Hynobius yiwuensis [J]. Hereditas(Beijing), 2025, 47(9): 1032-1041.
[2]	Ying Feng, Xiaoli He, Yu Liu, Jin Wang. Mass spectrometry-based analysis of RNA and its modifications [J]. Hereditas(Beijing), 2025, 47(8): 885-902.
[3]	Jiaojiao Liu, Xinhe Lu, Hongyan Yin, Hailong Zhou, Hanzeng Li, Shunqing Xu. Analysis of food preference behavior of C. elegans to Acinetobacter calcoaceticus based on transcriptomics [J]. Hereditas(Beijing), 2025, 47(7): 786-796.
[4]	Furong Cheng, Wenyu Song, Pengbo Cao, Gangqiao Zhou. Potential value of anoikis transcriptional signatures in predicting prognosis and immune microenvironment in hepatocellular carcinoma [J]. Hereditas(Beijing), 2025, 47(7): 768-785.
[5]	Rui He, Xiujuan Zheng, Ningning Wang, Xuying Li, Mingqi Li, Shijing Nian, Kewei Wang. Identification of PANoptosis-related lncRNAs in hepatocellular carcinoma based on bioinformatics and construction of a prognostic model [J]. Hereditas(Beijing), 2025, 47(4): 456-475.
[6]	Min Chen, Na Han, Yu Miao, Yujun Qiang, Wen Zhang, Pengbo Liu, Qiyong Liu, Dongmei Li. Differential transcriptome profiling of Bartonella spp. influenced by the species divergence factors [J]. Hereditas(Beijing), 2025, 47(3): 366-381.
[7]	Chaofei Han, Ling Chen, Yuanxiu Wang, Qian Cheng, Sheng Zuo, Huabin Liu, Chengliang Wang. Mining and analysis of key genes related to rice seed longevity in NJ9108 based on transcriptomics [J]. Hereditas(Beijing), 2025, 47(3): 351-365.
[8]	Heng Wei, Tianpeng Liu, Jihong He, Kongjun Dong, Ruiyu Ren, Lei Zhang, Yawei Li, Ziyi Hao, Tianyu Yang. Genome-wide identification of GRF transcription factors and their expression profile in stem meristem of broomcorn millet (Panicum miliaceum L.) [J]. Hereditas(Beijing), 2024, 46(3): 242-255.
[9]	Xin Wen, Jin Mei, Meiyu Qian, Yidan Jiang, Juan Wang, Shibo Xu, Cuizhe Wang, Jun Zhang. Screening and analysis of GULP1 downstream target genes based on transcriptomic sequencing [J]. Hereditas(Beijing), 2024, 46(10): 860-870.
[10]	Yuying Chen, Qian Zhang, Menghui Gui, Lan Feng, Pengbo Cao, Gangqiao Zhou. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2 [J]. Hereditas(Beijing), 2024, 46(1): 46-62.
[11]	Mengxuan Xu, Ming Zhou. Advances of RNA polymerase IV in controlling DNA methylation and development in plants [J]. Hereditas(Beijing), 2022, 44(7): 567-580.
[12]	Yan Guo, Lele Yang, Huayu Qi. Transcriptome analysis of mouse male germline stem cells reveals characteristics of mature spermatogonial stem cells [J]. Hereditas(Beijing), 2022, 44(7): 591-608.
[13]	Min Cheng, Jing Zhang, Pengbo Cao, Gangqiao Zhou. Prognostic and predictive value of the hypoxia-associated long non-coding RNA signature in hepatocellular carcinoma [J]. Hereditas(Beijing), 2022, 44(2): 153-167.
[14]	Changgui Lei, Xueyuan Jia, Wenjing Sun. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database [J]. Hereditas(Beijing), 2021, 43(7): 665-679.
[15]	Tianpei Shi,Li Zhang. Application of whole transcriptomics in animal husbandry [J]. Hereditas(Beijing), 2019, 41(3): 193-205.